Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

VCs Raise Cash For New Deals; Five Biotechs Find Funding

This article was originally published in Scrip

Executive Summary

Venture capitalists raised $12bn for new US-based funds in the first quarter of 2016, including a handful of VC firms that invest in biotechnology, which is good news for early-stage drug developers that hope to close new funding rounds, like their peers at Entasis Therapeutics did recently.

Advertisement

Related Content

Finance Watch: Lilly Cuts 3,500 Jobs Globally To Drive Growth
VC Roundup: Three New Funds Close As Small, Early Financings Bounce Back
VC Roundup: Caribou Completes $30m Non-IPO CRISPR Financing; $205m In Cash For Five Others
Biotech VC Funding Rises As Fewer Companies Get More Dollars

Topics

Advertisement
UsernamePublicRestriction

Register

SC064957

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel